학술논문

Commentary on Greenberg et al., "Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions" [Alzheimer's Dement. 2023; 9(4):e12426. doi.org/10.1002/trc2.12426].
Document Type
Article
Source
Alzheimer's & Dementia: Translational Research & Clinical Interventions; Jan2024, Vol. 10 Issue 1, p1-3, 3p
Subject
ALZHEIMER'S disease
CEREBRAL amyloid angiopathy
PUBLIC health infrastructure
VASCULAR dementia
IMMUNOTHERAPY
Language
ISSN
23528737
Abstract
Copyright of Alzheimer's & Dementia: Translational Research & Clinical Interventions is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)